Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One!
Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends
News Australia joins EU in turning down Alzheimer's drug Leqembi Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy Leqembi, saying its efficacy does not outweigh its risks.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
